Pricing Log in Create free account

Insight Molecular Diagnostics Inc. (IMDX) vs MBody AI Ltd. (MBAI)

Insight Molecular Diagnostics Inc. and MBody AI Ltd. are both Diagnostics & Research companies. Insight Molecular Diagnostics Inc. is the larger, with a market value of $100.1M against $47.4M — 2.1× the size. MBody AI Ltd. has the higher net margin (0.00% vs −2,955.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Insight Molecular Diagnostics Inc. leads on 7 and MBody AI Ltd. on 5.

Valuation

Metric IMDX MBAI Diagnostics & Research median
P/E n/m n/m 35.56
P/S 66.24 n/m 4.37
P/B n/m 0.61 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales 55.72 n/m 5.51
Earnings yield (49.50%) (763.41%) (1.89%)
Free cash flow yield (28.02%) (565.34%) (0.15%)

Profitability

Metric IMDX MBAI Diagnostics & Research median
Gross margin 48.32% 0.00% 50.89%
Operating margin (3,011.86%) 0.00% (8.57%)
Net margin (2,955.63%) 0.00% (6.37%)
Free cash flow margin (1,856.23%) 0.00% 0.00%
Return on equity 488.68% 0.00% (2.92%)
Return on assets (123.46%) 0.00% (6.71%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMDX MBAI Diagnostics & Research median
Revenue growth (TTM) (60.77%) — 7.69%
EPS growth (last fiscal year) 64.59% 115.35% 25.92%
Revenue growth, 5-year CAGR 27.24% — 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMDX MBAI Diagnostics & Research median
Debt to equity (0.04) 0.00 0.11
Current ratio 2.00 0.71 2.02
Net debt to EBITDA (0.67) 0.09 0.70

Dividend

Metric IMDX MBAI Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric IMDX MBAI Diagnostics & Research median
Market cap 100.14m 47.41m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack